Although myeloma is treatable, it is generally not curable, and advanced therapies like blood stem cell transplantation can ...

Revlimid is prescribed for adults with multiple myeloma. It may be taken by people with or without a past hematopoietic stem cell transplant (HSCT). (HSCT is a treatment for multiple myeloma in ...

Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Sanofi’s Sarclisa combined with Velcade ...

GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...

newly-diagnosed multiple myeloma (NDMM), there was no significant difference identified in the level of minimal residual disease (MRD) negativity with the use of single vs tandem autologous stem cell ...

Multiple myeloma is a type of cancer where plasma ... induction therapy with the above or similar drugs. At times, a stem cell transplant may be recommended. A long term, follow-up study from ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of CARVYKTI to transform outcomes in refractory multiple myeloma ...

AI’s role in speeding up turnaround times in stem cell donor matching and transplantation is being ... lymphoma, multiple myeloma, aplastic anaemia, sickle cell disease, thalassemia and other ...

By analyzing the mutations that occur throughout life in the donor and recipient's stem cells, they could track how many stem cells had survived the transplant process and continued to produce new ...

South African Bone Marrow Registry (SABMR) deputy director Jane Ward said AI’s role in speeding up the turnaround time in stem cell donor matching and transplantation was being investigated by ...